Basic neuroanatomy and neuropharmacology of cannabinoids

International Review of Psychiatry

Volumn 21, Issue 2 SPEC. ISS., 2009, Pages 113-121

  Breivogel, Chris S ^a   Sim Selley, Laura J ^b  

^a Campbell University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; CANNABINOID 2 RECEPTOR; CANNABIS; CELL NUCLEUS RECEPTOR; DEXANABINOL; DRONABINOL; ENDOCANNABINOID; ION CHANNEL; LEVONANTRADOL; NANTRADOL; NOLADIN ETHER; VIRODHAMINE;

ADDICTION; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; DEPRESSION; DRUG ABUSE; DRUG DEPENDENCE; DRUG MECHANISM; GILLES DE LA TOURETTE SYNDROME; HUMAN; LOW DRUG DOSE; NEUROANATOMY; NEUROPHARMACOLOGY; NONHUMAN; OBESITY; PAIN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSYCHOSIS; REVIEW; VOMITING;

ANIMALS; BRAIN; CANNABINOIDS; ENDOCANNABINOIDS; HUMANS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID;

EID: 67651034751     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.1080/09540260902782760     Document Type: Review

References (115)

1. Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C.E., Brenner, G.J. et al. (2007). Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nature Neuroscience, 10, 870-879. (Pubitemid 47013432)
2. Ahluwalia, J., Urban, L., Capogna, M., Bevan, S., & Nagy, I. (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685-688. (Pubitemid 30742272)
3. Ahn, K., McKinney, M.K., & Cravatt, B.F. (2008). Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev, 108, 1687-1707. (Pubitemid 351796405)
4. Akopian, A.N., Ruparel, N.B., Patwardhan, A., & Hargreaves, K.M. (2008). Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. Journal of Neuroscience, 28, 1064-1075. (Pubitemid 351186337)
5. Breivogel, C.S., & Childers, S.R. (1998). The functional neuroanatomy of brain cannabinoid receptors. Neurobiology of Disease, 5, 417-431.
6. Breivogel, C.S., Griffin, G., Di Marzo, V., & Martin, B.R. (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology, 60, 155-163. (Pubitemid 32595243)
7. Breivogel, C.S., Selley, D.E., & Childers, S.R. (1998). Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. Journal of Biological Chemistry, 273, 16865-16873.
8. Breivogel, C.S., Sim, L.J., & Childers, S.R. (1997). Regional differences in cannabinoid receptor/G-protein coupling in rat brain. Journal of Pharmacology and Experimental Therapeutics, 282, 1632-1642.
9. Breivogel, C.S., Walker, J.M., Huang, S.M., Roy, M.B., & Childers, S.R. (2004). Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. Neuropharmacology, 47, 81-91.
10. Brusco, A., Tagliaferro, P., Saez, T., & Onaivi, E.S. (2008). Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse, 62, 944-949.
11. Caterina, M.J., Rosen, T.A., Tominaga, M., Brake, A.J., & Julius, D. (1999). A capsaicin-receptor homologue with a high threshold for noxious heat. Nature, 398, 436-441. (Pubitemid 29180377)
12. Chhatwal, J.P., & Ressler, K.J. (2007). Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectrums, 12, 211-220.
13. Compton, D.R., Rice, K.C., DeCosta, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R. et al. (1993). Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. Journal of Pharmacology and Experimental Therapeutics, 265, 218-226.
14. Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., & Di Marzo, V. (2006). Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience, 139, 1405-1415.
15. Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001). Studies on [3H]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience, 103, 9-15.
16. DeSanty, K.P., & Dar, M.S. (2001). Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. Pharmacology, Biochemistry and Behavior, 69, 251-259.
17. Devane, W.A., Dysarz, F.A. 3rd, Johnson, M.R., Melvin, L.S., & Howlett, A.C. (1998). Determination and characterization of a cannabinoid receptor in brain. Molecular Pharmacology, 34, 605-613.
18. Di, S., Malcher-Lopes, R., Halmos, K.C., & Tasker, J.G. (2003). Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: A fast feedback mechanism. Journal of Neuroscience, 23, 4850-4857. (Pubitemid 36793211)
19. Diana, M., Melis, M., Muntoni, A.L., & Gessa, G.L. (1998). Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proceedings of the National Academy of Science of the United States of America, 95, 10269-10273. (Pubitemid 28415330)
20. Egertova, M., Cravatt, B.F., & Elphick, M.R. (2003). Comparative analysis of fatty acid amide hydrolase and CB(1) cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience, 119, 481-496.
21. Egertova, M., & Elphick, M.R. (2000). Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. Journal of Comparative Neurology, 422, 159-171. (Pubitemid 30390161)
22. Egertova, M., Giang, D.K., Cravatt, B.F., & Elphick, M.R. (1998). A new perspective on cannabinoid signalling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proceedings of the Royal Society B: Biological Sciences, 265, 2081-2085. (Pubitemid 28502544)
23. Eggan, S.M., Hashimoto, T., & Lewis, D.A. (2008). Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of General Psychiatry, 65, 772-784. (Pubitemid 351957703)
24. Eggan, S.M., & Lewis, D.A. (2007). Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: A regional and laminar analysis. Cerebral Cortex, 17, 175-191.
25. Farquhar-Smith, W.P., Egertova, M., Bradbury, E.J., McMahon, S.B., Rice, A.S., & Elphick, M.R. (2000). Cannabinoid CB(1) receptor expression in rat spinal cord. Molecular and cellular neurosciences, 15, 510-521.
26. Fattore, L., Spano, M.S., Altea, S., Angius, F., Fadda, P., & Fratta, W. (2007). Cannabinoid self-administration in rats: Sex differences and the influence of ovarian function. British Journal of Pharmacology, 152, 795-804. (Pubitemid 350034986)
27. Fields, H.L., Heinricher, M.M., & Mason, P. (1991). Neurotransmitters in nociceptive modulatory circuits. Annual Review of Neuroscience, 14, 219-245.
28. Fitton, A.G., & Pertwee, R.G. (1982). Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol. British Journal of Pharmacology, 75, 409-414.
29. French, E.D. (1997). Delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neuroscience Letters, 226, 159-162.
30. Fried, P.A., & Smith, A.M. (2001). A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology, 23, 1-11.
31. Gaoni, Y., & Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society, 86, 1646-1647.
32. Gardner, E.L., & Vorel, S.R. (1998). Cannabinoid transmission and reward-related events. Neurobiology of Disease, 5, 502-533.
33. Glass, M., Dragunow, M., & Faull, R.L.M. (1997). Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 77, 299-318. (Pubitemid 27079604)
34. Glass, M., & Felder, C.C. (1997). Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor. The Journal of Neuroscience, 17, 5327-5333. (Pubitemid 27300300)
35. Glass, M., & Northup, J.K. (1999). Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Molecular Pharmacology, 56, 1362-1369.
36. Gong, J.P., Onaivi, E.S., Ishiguro, H., Liu, Q.R., Tagliaferro, P.A., Brusco, A. et al. (2006). Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Research, 1071, 10-23. (Pubitemid 43255471)
37. Gulyas, A.I., Cravatt, B.F., Bracey, M.H., Dinh, T.P., Piomelli, D., Boscia, F. et al. (2004). Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. European Journal of Neuroscience, 20, 441-458. (Pubitemid 38969629)
38. Hagenacker, T., Ledwig, D., & Busselberg, D. (2008). Feedback mechanisms in the regulation of intracellular calcium ([Ca2+]i) in the peripheral nociceptive system: Role of TRPV-1 and pain related receptors. Cell Calcium, 43, 215-227.
39. Haney, M., Ward, A.S., Comer, S.D., Foltin, R.W., & Fischman, M.W. (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology, 141, 395-404. (Pubitemid 29190008)
40. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R., & Rice, K.C. (1991). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience, 11, 563-583.
41. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R. et al. (1990). Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences of the United States of America, 87, 1932-1936.
42. Hollister, L.E. (1986). Health aspects of cannabis. Pharmacological Reviews, 38, 1-20.
43. Howlett, A.C. (1984). Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sciences, 35, 1803-1810. (Pubitemid 14033077)
44. Howlett, A.C., Breivogel, C.S., Childers, S.R., Deadwyler, S.A., Hampson, R.E., & Porrino, L.J. (2004). Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology, 47(Suppl.1), 345-358. (Pubitemid 39298276)
45. Jansen, E.M., Haycock, D.A., Ward, S.J., & Seybold, V.S. (1992). Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Research, 575, 93-102.
46. Jhaveri, M.D., Elmes, S.J., Richardson, D., Barrett, D.A., Kendall, D.A., Mason, R. et al. (2008). Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. European Journal of Neuroscience, 27, 1722-1730.
47. Jones, R.T., Benowitz, N.L., & Herning, R.I. (1981). Clinical relevance of cannabis tolerance and dependence. Journal of Clinical Pharmacology, 21, 143S-152S.
48. Jonsson, K.O., Holt, S., & Fowler, C.J. (2006). The endocannabinoid system: Current pharmacological research and therapeutic possibilities. Basic & Clinical Pharmacology & Toxicology, 98, 124-134.
49. Katona, I., Rancz, E.A., Acsady, L., Ledent, C., Mackie, K., Hajos, N. et al. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. Journal of Neuroscience, 21, 9506-9518. (Pubitemid 33096895)
50. Katona, I., Urban, G.M., Wallace, M., Ledent, C., Jung, K.M., Piomelli, D. et al. (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. Journal of Neuroscience, 26, 5628-5637. (Pubitemid 44315254)
51. Kearn, C.S., Blake-Palmer, K., Daniel, E., Mackie, K., & Glass, M. (2005). Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk? Molecular Pharmacology, 67, 1697-1704.
52. Kim, D., Cavanaugh, E.J., & Simkin, D. (2008). Inhibition of transient receptor potential A1 channel by phosphatidylinositol-4,5- bisphosphate. American Journal of Physiology - Cell Physiology, 295, C92-99. (Pubitemid 352755793)
53. Koethe, D., Llenos, I.C., Dulay, J.R., Hoyer, C., Torrey, E.F., Leweke, F.M. et al. (2007). Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. Journal of Neural Transmission, 114, 1055-1063.
54. Kogan, N.M., & Mechoulam, R. (2007). Cannabinoids in health and disease. Dialogues in Clinical Neuroscience, 9, 413-430.
55. Kowase, T., Nakazato, Y., Yoko, O.H., Morikawa, A., & Kojima, I. (2002). Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues. Endocrine Journal, 49, 349-355. (Pubitemid 34832308)
56. Kreitzer, A.C., & Regehr, W.G. (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29, 717-727.
57. Lauckner, J.E., Jensen, J.B., Chen, H.Y., Lu, H.C., Hille, B., & Mackie, K. (2008). GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proceedings of the National Academy of Sciences USA, 105, 2699-2704.
58. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F. et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401-404. (Pubitemid 129501104)
59. Lichtman, A.H., & Martin, B.R. (1991). Spinal and supraspinal components of cannabinoid-induced antinociception. Journal of Pharmacology and Experimental Therapeutics, 258, 517-523.
60. Lidow, M.S., Williams, G.V., & Goldman-Rakic, P.S. (1998). The cerebral cortex: A case for a common site of action of antipsychotics. Trends in Pharmacological Sciences, 19, 136-140.
61. Lupica, C.R., Riegel, A.C., & Hoffman, A.F. (2004). Marijuana and cannabinoid regulation of brain reward circuits. British Journal of Pharmacology, 143, 227-234. (Pubitemid 39315142)
62. Maccarrone, M., Rossi, S., Bari, M., De Chiara, V., Fezza, F., Musella, A. et al. (2008). Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nature Neuroscience, 11, 152-159. (Pubitemid 351170502)
63. Mackie, K. (2005). Cannabinoid receptor homo- and heterodimerization. Life Sciences, 77, 1667-1673.
64. Marsicano, G., & Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. European Journal of Neuroscience, 11, 4213-4225. (Pubitemid 30009252)
65. Martin, W.J., Hohmann, A.G., & Walker, J.M. (1996). Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: Correlation between electrophysiological and antinociceptive effects. Journal of Neuroscience, 16, 6601-6611.
66. Martin, W.J., Patrick, S.L., Coffin, P.O., Tsou, K., & Walker, J.M. (1995). An examination of the central sites of action of cannabinoid-induced antinociception in the rat. Life Sciences, 56, 2103-2109.
67. Martin, W.J., Tsou, K., & Walker, J.M. (1998). Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla. Neuroscience Letters, 242, 33-36. (Pubitemid 28122702)
68. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., & Bonner, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564. (Pubitemid 20238806)
69. Melis, M., Pistis, M., Perra, S., Muntoni, A.L., Pillolla, G., & Gessa, G.L. (2004). Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. Journal of Neuroscience, 24, 53-62. (Pubitemid 38181669)
70. Meng, I.D., Manning, B.H., Martin, W.J., & Fields, H.L. (1998). An analgesia circuit activated by cannabinoids. Nature, 395, 381-383.
71. Michalik, L., Auwerx, J., Berger, J.P., Chatterjee, V.K., Glass, C.K., Gonzalez, F.J. et al. (2006). International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacological Reviews, 58, 726-741.
72. Monory, K., Blaudzun, H., Massa, F., Kaiser, N., Lemberger, T., Schutz, G. et al. (2007). Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice. PLoS Biol, 5, 2354-2368.
73. Morgan, C.J., & Curran, H.V. (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. British Journal of Psychiatry, 192, 306-307.
74. Movahed, P., Jonsson, B.A., Birnir, B., Wingstrand, J.A., Jorgensen, T.D., Ermund, A. et al. (2005). Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists. Journal of Biological Chemistry, 280, 38496-38504. (Pubitemid 43853748)
75. Munro, S., Thomas, K.L., & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65. (Pubitemid 23305569)
76. Navarrete, M., & Araque, A. (2008). Endocannabinoids mediate neuron-astrocyte communication. Neuron, 57, 883-893.
77. Newell, K.A., Deng, C., & Huang, X.F. (2006). Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Experimental Brain Research, 172, 556-560. (Pubitemid 43989359)
78. O'Sullivan, S.E. (2007). Cannabinoids go nuclear: Evidence for activation of peroxisome proliferator-activated receptors. British Journal of Pharmacology, 152, 576-582. (Pubitemid 350034977)
79. Onaivi, E.S., Ishiguro, H., Gong, J.P., Patel, S., Perchuk, A., Meozzi, P.A. et al. (2006). Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Annals of the New York Academy of Sciences, 1074, 514-536. (Pubitemid 44532857)
80. Ong, W.Y., & Mackie, K. (1999). A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience, 92, 1177-1191. (Pubitemid 29292558)
81. Patel, S., & Hillard, C.J. (2001). Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. Journal of Pharmacology and Experimental Therapeutics, 297, 629-637. (Pubitemid 32377994)
82. Pertwee, R.G., & Wickens, A.P. (1991). Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology, 30, 237-244.
83. Pickel, V.M., Chan, J., Kash, T.L., Rodriguez, J.J., & MacKie, K. (2004). Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience, 127, 101-112. (Pubitemid 38829156)
84. Pickel, V.M., Chan, J., Kearn, C.S., & Mackie, K. (2006). Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. Journal of Comparative Neurology, 495, 299-313. (Pubitemid 43271474)
85. Piomelli, D. (2003). The molecular logic of endocannabinoid signalling. Nature Reviews Pharmacology, 4, 873-884.
86. Prather, P.L., Martin, N.A., Breivogel, C.S., & Childers, S.R. (2000). Activation of cannabinoid receptors in rat brain by WIN 55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Molecular Pharmacology, 57, 1000-1010.
87. Qin, N., Neeper, M.P., Liu, Y., Hutchinson, T.L., Lubin, M.L., & Flores, C.M. (2008). TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. Journal of Neuroscience, 28, 6231-6238.
88. Rawls, S.M., Cabassa, J., Geller, E.B., & Adler, M.W. (2002). CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl) -6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia. Journal of Pharmacology and Experimental Therapeutics, 301, 963-968. (Pubitemid 34595086)
89. Rios, C., Gomes, I., & Devi, L.A. (2006). Mu opioid and CB1 cannabinoid receptor interactions: Reciprocal inhibition of receptor signaling and neuritogenesis. British Journal of Pharmacology, 148, 387-395. (Pubitemid 43882074)
90. Romero, J., Hillard, C.J., Calero, M., & Rabano, A. (2002). Fatty acid amide hydrolase localization in the human central nervous system: An immunohistochemical study. Molecular Brain Research, 100, 85-93. (Pubitemid 34465581)
91. Ryberg, E., Larsson, N., Sjogren, S., Hjorth, S., Hermansson, N.O., Leonova, J. et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology, 152, 1092-1101. (Pubitemid 350166046)
92. Sagar, D.R., Kelly, S., Millns, P.J., O'Shaughnessey, C.T., Kendall, D.A., & Chapman, V. (2005). Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. European Journal of Neuroscience, 22, 371-379. (Pubitemid 41097610)
93. Salio, C., Doly, S., Fischer, J., Franzoni, M.F., & Conrath, M. (2002). Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neuroscience Letters, 329, 13-16. (Pubitemid 34895026)
94. Sawzdargo, M., Nguyen, T., Lee, D.K., Lynch, K.R., Cheng, R., Heng, H.H. et al. (1999). Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Molecular Brain Research, 62, 193-198.
95. Sim-Selley, L.J. (2003). Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Critical Reviews in Neurobiology, 15, 91-119. (Pubitemid 38160440)
96. Sim-Selley, L.J., Vogt, L.J., Vogt, B.A., & Childers, S.R. (2002). Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex. Life Sciences, 71, 2217-2226.
97. 35S]GTPgS autoradiography in rat brain. Journal of Neuroscience, 16, 8057-8066.
98. Sim, L.J., Selley, D.E., & Childers, S.R. (1995). In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proceedings of the National Academy of Sciences of the United States of America, 92, 7242-7246.
99. Simon, G.M., & Cravatt, B.F. (2008). Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J Biol Chem, 283, 9341-9349.
100. Sun, Y., Alexander, S.P., Garle, M.J., Gibson, C.L., Hewitt, K., Murphy, S.P. et al. (2007). Cannabinoid activation of PPAR alpha; A novel neuroprotective mechanism. British Journal of Pharmacology, 152, 734-743. (Pubitemid 350034991)
101. Svizenska, I., Dubovy, P., & Sulcova, A. (2008). Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - A short review. Pharmacology, Biochemistry and Behavior, 90, 501-511.
102. Tanda, G., Loddo, P., & Di Chiara, G. (1999). Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. European Journal of Pharmacology, 376, 23-26. (Pubitemid 29320166)
103. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K., & Walker, J.M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411. (Pubitemid 28062631)
104. Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K. et al. (2005). Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 310, 329-332.
105. Villares, J. (2007). Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain. Neuroscience, 145, 323-334.
106. Wager-Miller, J., Westenbroek, R., & Mackie, K. (2002). Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. Chemistry and Physics of Lipids, 121, 83-89. (Pubitemid 36044545)
107. Walter, L., Franklin, A., Witting, A., Moller, T., & Stella, N. (2002). Astrocytes in culture produce anandamide and other acylethanolamides. Journal of Biological Chemistry, 277, 20869-20876. (Pubitemid 34967395)
108. Wang, X., Dow-Edwards, D., Keller, E., & Hurd, Y.L. (2003). Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience, 118, 681-694. (Pubitemid 36506956)
109. Wiley, J.L., Kendler, S.H., Burston, J.J., Howard, D.R., Selley, D.E., & Sim-Selley, L.J. (2008). Antipsychotic-induced alterations in CB(1) receptor-mediated G-protein signaling and in vivo pharmacology in rats. Neuropharmacology, 55, 1183-1190.
110. Wilson, R.I., & Nicoll, R.A. (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 410, 588-592.
111. Wright, S. (2007). Cannabinoid-based medicines for neurological disorders - Clinical evidence. Molecular neurobiology, 36, 129-136. (Pubitemid 351360352)
112. Yoshida, T., Fukaya, M., Uchigashima, M., Miura, E., Kamiya, H., Kano, M. et al. (2006). Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. Journal of Neuroscience, 26, 4740-4751. (Pubitemid 44315313)
113. Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S.R., & Wise, R.A. (2006). Two brain sites for cannabinoid reward. The Journal of Neuroscience, 26, 4901-4907. (Pubitemid 44315331)
114. Zavitsanou, K., Garrick, T., & Huang, X.F. (2004). Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Progress in Neuro- Psychopharmacology and Biological Psychiatry, 28, 355-360.
115. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M., & Bonner, T.I. (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America, 96, 5780-5785. (Pubitemid 29234695)